Company Description

EVER Pharma is a fully integrated specialty pharmaceuticalscompany dedicated to the research, development, production, andcommercialization of products in the areas of neurology and specialtyinjectables. Their product portfolio covers oncology, intensive care, andhormone therapeutics, making them a leader in their field.

Problem Statement

Sandoz, a global leader in the pharmaceuticals industry, decided to sell its department for neurologic pharmaceuticals to EVER Pharma. This carve-out required a meticulous separation of data and systems specific to the neurologic pharmaceuticals department, ensuring a seamless transition to EVER Pharma. This carve-outs did not use standard SAP solutions, custom ABAP functionality was developed to meet data migration and system setup requirements.

Solution That Was Implemented

To address this complex carve-out, a comprehensive migration strategy was implemented. The key steps involved:

1. Data Migration: A meticulous data migration process was undertaken to ensure that all relevant data from the neurologic pharmaceuticals department was accurately transferred to EVER Pharma. This was crucial to maintain data integrity and operational continuity.
2. ABAP Utilization: Advanced Business Application Programming (ABAP) was utilized to delete unnecessary data through archive functions. This ensured that only the essential data specific to the neurologic pharmaceuticals department was retained and transferred, facilitating a clean and efficient migration.
3. Standalone System Setup: A standalone SAP system was established for EVER Pharma. This approach allowed EVER Pharma to operate independently without the need to reimplement a new system from scratch, leveraging the existing infrastructure to ensure continuity and efficiency.

Value Added

The implementation of this solution provided significant value to both Sandoz and EVER Pharma:

• Efficient Transition: By using ABAP and archive functions, the data migration process was streamlined, ensuring a clean and efficient transition without the need for a complete system reimplementation.
• Operational Continuity: EVER Pharma could continue its operations seamlessly on the current system, benefiting from an established infrastructure without the disruptions typically associated with setting up a new system.
• Cost and Time Savings: The approach eliminated the need for a costly and time-consuming reimplementation of a new system, providing a cost-effective solution that facilitated a smooth and timely transition.

In conclusion, the carve-out of Sandoz's neurologic pharmaceuticals department to EVER Pharma was executed with precision and efficiency. By leveraging ABAP for data deletion and setting up a standalone system, the transition was seamless, maintaining operational continuity and avoiding the need for a new system reimplementation. This case study underscores the importance of strategic data migration and tailored solutions in executing successful carve-outs in the pharmaceuticals industry.